| Involvement of chemokine receptors in breast cancer metastasis A Müller, B Homey, H Soto, N Ge, D Catron, ME Buchanan, ... nature 410 (6824), 50-56, 2001 | 7086 | 2001 |
| Consenting of the vulnerable: the informed consent procedure in advanced cancer patients in Mexico EL Verástegui BMC Medical Ethics 7, 1-12, 2006 | 92 | 2006 |
| Long-term immune dysfunction after radiotherapy to the head and neck area EL Verastegui, RB Morales, JL Barrera-Franco, AC Poitevin, J Hadden International immunopharmacology 3 (8), 1093-1104, 2003 | 71 | 2003 |
| Creencias, actitudes y ansiedad ante la muerte en un equipo multidisciplinario de cuidados paliativos oncológicos LA Huertas, SRA Pérez, EV Avilés Psicooncología 11 (1), 101, 2014 | 70 | 2014 |
| Involvement of chemokine receptors in breast cancer metastasis E Murphy, W Yuan, SN Wagner, JL Barrera, A Mohar, E Verastegui, ... Nature 410 (6824), 5056, 2001 | 62 | 2001 |
| Combination immunotherapy of squamous cell carcinoma of the head and neck: a phase 2 trial JL Barrera, E Verastegui, A Meneses, J Zinser, J de la Garza, JW Hadden Archives of Otolaryngology–Head & Neck Surgery 126 (3), 345-351, 2000 | 57 | 2000 |
| Assessment and impact of phase angle and sarcopenia in palliative cancer patients DA Pérez Camargo, SR Allende Pérez, E Verastegui Avilés, ... Nutrition and Cancer 69 (8), 1227-1233, 2017 | 50 | 2017 |
| Lymph node histology in head and neck cancer: impact of immunotherapy with IRX-2 A Meneses, E Verastegui, JL Barrera, J de la Garza, JW Hadden International immunopharmacology 3 (8), 1083-1091, 2003 | 48 | 2003 |
| Histologic findings in patients with head and neck squamous cell carcinoma receiving perilymphatic natural cytokine mixture (IRX-2) prior to surgery A Meneses, E Verastegui, JL Barrera, J Zinser Archives of pathology & laboratory medicine 122 (5), 447, 1998 | 44 | 1998 |
| A natural cytokine mixture (IRX-2) and interference with immune suppression induce immune mobilization and regression of head and neck cancer E Verastegui, JL Barrera, J Zinser, R Del Rio, A Meneses, J De La Garza, ... International journal of immunopharmacology 19 (11-12), 619-627, 1998 | 42 | 1998 |
| Colorectal cancer in Mexico: should a middle income country invest in screening or in treatment? E Verastegui, A Mohar The European Journal of Health Economics 10, 107-114, 2010 | 37 | 2010 |
| A trial of IRX-2 in patients with squamous cell carcinomas of the head and neck J Hadden, E Verastegui, JL Barrera, M Kurman, A Meneses, JW Zinser, ... International immunopharmacology 3 (8), 1073-1081, 2003 | 36 | 2003 |
| Immunological approach in the evaluation of regional lymph nodes of patients with squamous cell carcinoma of the head and neck E Verastegui, R Morales, JL Barrera, A Müeller, J Hadden, B Guzman, ... Clinical immunology 102 (1), 37-47, 2002 | 36 | 2002 |
| Automedicación y autoprescripción A Lifshitz, O Arrieta, R Burgos, C Campillo, MÁ Celis, M Llata, ... Gaceta médica de México 156 (6), 612-614, 2020 | 34 | 2020 |
| Bispectral Index monitoring in cancer patients undergoing palliative sedation: a preliminary report E Monreal-Carrillo, S Allende-Pérez, D Hui, MF García-Salamanca, ... Supportive Care in Cancer 25, 3143-3149, 2017 | 34 | 2017 |
| Frecuencia de anorexia-caquexia y su asociación con síntomas gastrointestinales, en pacientes paliativos del Instituto Nacional de Cancerología, México DA Pérez Camargo, SR Allende Pérez, A Meneses García, ... Nutrición Hospitalaria 30 (4), 891-895, 2014 | 24 | 2014 |
| El consentimiento informado: recomendaciones para su documentación MÁ Celis, J Halabe, O Arrieta, R Burgos, C Campillo, M De la Llata, ... Gaceta Médica de México 154 (6), 716-718, 2018 | 21 | 2018 |
| IRX‐2 and Thymosin α1 (Zadaxin) Increase T Lymphocytes in T Lymphocytopenic Mice and Humans JW Hadden, E Verastegui, E Hadden Annals of the New York Academy of Sciences 1112 (1), 245-255, 2007 | 21 | 2007 |
| Self-medication and self-prescription A Lifshitz, O Arrieta, R Burgos, C Campillo, MÁ Celis, M Llata, ... Gaceta médica de México 156 (6), 612-614, 2020 | 18 | 2020 |
| Integrated oncology and palliative care: five years experience at the National Cancer Institute of Mexico S Allende-Pérez, E Verástegui-Avilés, A Mohar-Betancourt, ... salud pública de méxico 58, 317-324, 2016 | 18 | 2016 |
